Last updated on
Living in a Post-Pandemic World: What Medicine Has Learned in the Last Year Enduring
This course has expired for CME credit, however you can still view and access the event recording.
ACTIVITY DESCRIPTION / STATEMENT OF NEED:
Living in a Post-Pandemic World: What Medicine Has Learned in the Last Year focuses on key lessons learned during the COVID-19 pandemic, including how mRNA vaccine technology may be leveraged in cardiovascular medicine, what we know about thromboinflammation in COVID-19, the potential effects of long COVID syndrome on our patients and the healthcare system, and how clinicians can begin to address both the consequences of delayed cardiac care and the myriad healthcare inequities that have been uncovered over the last 18 months.
The content of this internet enduring material activity was originally presented as part of a live event. Learners must view all videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.
This program has been designed for physicians, nurse practitioners, physician assistants, pharmacists, and other clinicians specializing in cardiology, family medicine, hematology, hospital medicine, infectious disease, internal medicine, pulmonology and critical care, rheumatology, and vascular medicine.
By the end of the session the participant will be able to:
- Recall how mRNA technology used to develop vaccines for COVID-19 can be leveraged in cardiovascular medicine
- Explain how the link between inflammation and thrombosis that has characterized COVID-19 has implications for other aspects of medicine
- Describe long COVID syndrome and how medicine will handle this complication of COVID-19
- Summarize trends in cardiovascular care utilization during the COVID-19 pandemic and implications for future burden of disease and formulate a patient care plan based on that information
- Recognize healthcare disparities exposed by COVID-19 and how medicine needs to make changes for the health of all our communities
|President’s Perspective & Welcome|
Samuel Z. Goldhaber, MD – Harvard Medical School
Riding the Wave of mRNA Vaccine Technology: Applications in Cardiovascular Medicine
Kathryn E. Stephenson, MD, MPH – Assistant Professor of Medicine, Harvard Medical School Staff Physician, Division of Infectious Diseases, Beth Israel Deaconess Medical Center
Thromboinflammation in COVID-19: Lessons in Thrombosis for a Post-Pandemic World
Peter Libby, MD – Mallinckrodt Professor of Medicine, Harvard Medical School
Cardiovascular Specialist, Brigham and Women’s Hospital
Long COVID Syndrome: A Pandemic After the Pandemic?
Kristin Englund, MD, MLS – Assistant Professor, Cleveland Clinic Lerner College of Medicine of CWRU Staff Physician, Cleveland Clinic
Missed and Delayed Cardiovascular Care during the COVID-19 Pandemic: Consequences for Population Health
Karen Joynt Maddox, MD, MPH – Associate Professor, Washington University School of Medicine Cardiologist, Barnes-Jewish Hospital
Healthcare Disparities Exposed: How COVID-19 Showed Us That We Need to Do Better
Cassandra Pierre, MD, MSc – Assistant Professor of Medicine, Boston University School of Medicine Associate Hospital Epidemiologist, Boston Medical Center
FACULTY DISCLOSURES AND RESOLUTION OF COI
Samuel Z. Goldhaber, MD: Research Grants – Alexion, Amgen, Bayer, Bristol-Myers Squibb, Pfizer, BSC, Janssen; Consultant – Agile, Bayer, Pfizer
Peter Libby, MD: Research Grants – Novartis; Consultant – Amgen, AstraZeneca, Baim Institute, Beren Therapeutics, Esperion Therapeutics, Genentech, Kancera, Kowa Pharmaceuticals, Medimmune, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi-Regeneron; Scientific Advisory Board – Amgen, Caristo Diagnostics, Cartesian Therapeutics, Corvidia Therapeutics, CSL Behring, DalCor Pharmaceuticals, Dewpoint Therapeutics, Kancera, Kowa Pharmaceuticals, Olatee Therapeutics, Medimmune, Novartis, PlaqueTec, XBiotech, Inc.
Karen Joynt Maddox, MD, MPH: Health Policy Advocate Committee – Centene Corporation
Gregory Piazza, MD, MS: Research Grants – Alexion, Amgen, Bayer, BMS/Pfizer, BSC, Janssen
Individuals with no conflicts of interest to disclose:
- Content reviewer: Charles J Turck, PharmD, BCPS, BCCCP, President, ScientiaCME
- Kristin Englund, MD, MLS
- Cassandra Pierre, MD, MPH
- Kathryn E. Stephenson, MD, MPH